Every-three-week versus dose dense weekly paclitaxel neoadjuvant chemotherapy for advanced stage ovarian, fallopian tube, and peritoneal cancers
Year: 2014
Type: article
Study design: Observational Study
Source: Gynecologic Oncology
Language: English
Subfield: Reproductive Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W1982646927
